Literature DB >> 20807992

Delivering regional thrombolysis via a hub-and-spoke model.

Barry Moynihan1, Daniel Davis, Anthony Pereira, Geoffrey Cloud, Hugh S Markus.   

Abstract

OBJECTIVES: Audits in the United Kingdom and other countries show that only a small proportion of eligible stroke patients receive thrombolysis. Providing 24-hour thrombolysis cover presents major challenges in both infrastructure and staffing. One model for improving access is to provide out-of-hours cover in a regional centre but this may present problems including greater delays to hospital admissions.
DESIGN: Evaluation of the introduction of a 'hub-and-spoke' model of thrombolysis to increase access to thrombolysis for patients in south west London. One-year data are presented.
SETTING: A network in south-west London comprised of a hub hospital and three district 'spoke' hospitals. PARTICIPANTS: All suspected stroke admissions to a regional stroke centre. Main outcome measures Thrombolysis rates for acute stroke.
RESULTS: Increased out-of-hours thrombolysis rates were achieved with only a small increase in stroke admissions (approximately 10%) in the hub hospital. Thrombolysis rates increased from 1.2 per 100 stroke admissions for the local daytime service to 6 per 100 admissions for the regional service. Most patients thrombolysed were not local to the hub hospital. Only 1 in 4 patients considered for thrombolysis was thrombolysed, in line with previous data. Ten percent of all thrombolysis calls were not stroke but represented stroke mimics. Median length of stay was 6 days (target was 3 days). Fifty percent of the thrombolysed patients from spoke hospitals were discharged directly home.
CONCLUSIONS: In an urban area, a hub-and-spoke thrombolysis model increased access to thrombolysis without resulting in a marked increase in overall stroke admission numbers for the hub hospital. Proactive plans to repatriate patients back to district hospitals are required, and repatriation protocols have to prioritize regional patients over other targets in spoke hospitals to facilitate capacity in the hub hospital.

Entities:  

Mesh:

Year:  2010        PMID: 20807992      PMCID: PMC2930922          DOI: 10.1258/jrsm.2010.090434

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  5 in total

1.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

2.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

3.  Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients.

Authors:  A Mohd Nor; C McAllister; S J Louw; A G Dyker; M Davis; D Jenkinson; G A Ford
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

Review 4.  Systematic review of stroke thrombolysis service configuration.

Authors:  Christopher I Price; Fiona Clement; Joanne Gray; Cam Donaldson; Gary A Ford
Journal:  Expert Rev Neurother       Date:  2009-02       Impact factor: 4.618

5.  Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test.

Authors:  Joseph Harbison; Omar Hossain; Damian Jenkinson; John Davis; Stephen J Louw; Gary A Ford
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

  5 in total
  6 in total

1.  The organisation of the acute ischemic stroke management: key notes of the Italian Neurological Society and of the Italian Stroke Organization.

Authors:  E Agostoni; A Carolei; G Micieli; L Provinciali; D Toni; Simone Vidale
Journal:  Neurol Sci       Date:  2017-11-27       Impact factor: 3.307

2.  Stroke mimic diagnoses presenting to a hyperacute stroke unit.

Authors:  Ang Dawson; Geoffrey C Cloud; Anthony C Pereira; Barry J Moynihan
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

Review 3.  The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models.

Authors:  Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens
Journal:  J Neurol       Date:  2012-08-23       Impact factor: 4.849

Review 4.  Mechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical Practice.

Authors:  Murugan Palaniswami; Bernard Yan
Journal:  Interv Neurol       Date:  2015-09-18

Review 5.  How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.

Authors:  Christine L Paul; Annika Ryan; Shiho Rose; John R Attia; Erin Kerr; Claudia Koller; Christopher R Levi
Journal:  Implement Sci       Date:  2016-04-08       Impact factor: 7.327

Review 6.  Mandatory Neuroendovascular Evolution: Meeting the New Demands.

Authors:  Mohammad El-Ghanem; Francisco E Gomez; Prateeka Koul; Rolla Nuoman; Justin G Santarelli; Krishna Amuluru; Chirag D Gandhi; Eric R Cohen; Philip Meyers; Fawaz Al-Mufti
Journal:  Interv Neurol       Date:  2018-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.